LifeNews reports. Excerpts:
Wesley Smith, an attorney and bioethics
watchdog, responded to the news.
"Geron Corporation has released a
series of press releases over several years stating that 'next year' it would
start the first human trials using ES cells. Apparently, that won't be
happening yet," he said.
"Tumors are an important worry, as is
efficacy. Meanwhile, those adult stem cell advances keep rolling in," he
added.
…
[Senator] Brownback said human trials
involving embryonic stem cell research are unnecessary given the enormous
success scientists have had with adult stem cells.
“What makes this even more troubling is
that there is a viable ethical alternative with adult stem cells," he
said.
"They are currently being used in the
treatment of well over 70 different diseases and conditions, including spinal
cord injury, type-I diabetes, heart failure, and Parkinson’s disease as
validated by peer-reviewed, published results."